Seeing Is Believing
Currently out of the existing stock ratings of Liisa Bayko, 95 are a BUY (90.48%), 10 are a HOLD (9.52%).
Analyst Liisa Bayko, currently employed at EVERCORE, carries an average stock price target met ratio of 46.93% that have a potential upside of 54.3% achieved within 260 days.
Liisa Bayko’s has documented 242 price targets and ratings displayed on 25 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on KNSA, Kiniksa Pharmaceuticals Ltd at 30-Oct-2024.
Analyst best performing recommendations are on EDIT (EDITAS MEDICINE).
The best stock recommendation documented was for SRPT (SAREPTA THERAPEUTICS) at 1/9/2018. The price target of $60 was fulfilled within 3 days with a profit of $3.85 (6.86%) receiving and performance score of 22.86.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$5
$1.36 (37.36%)
$5
15 days ago
(07-Nov-2024)
0/15 (0%)
$1.27 (34.05%)
Buy
$5
$1.36 (37.36%)
$4
3 months 20 days ago
(02-Aug-2024)
2/6 (33.33%)
$1.26 (33.69%)
256
Buy
$4
$0.36 (9.89%)
$4
5 months 17 days ago
(05-Jun-2024)
4/10 (40%)
$0.37 (10.19%)
136
Buy
$5
$2.08 (71.23%)
2 years 9 months 20 days ago
(02-Feb-2022)
0/1 (0%)
$2.11 (73.01%)
Buy
$7
3 years 4 months 25 days ago
(28-Jun-2021)
0/4 (0%)
$3.7 (112.12%)
Which stock is Liisa Bayko is most bullish on?
Which stock is Liisa Bayko is most reserved on?
What Year was the first public recommendation made by Liisa Bayko?